Figure 2
Complex interaction between adipokines in β-cell specific effects. Many adipokines act via post-receptor pathways in the β-cell
which intersect in a number of places. In addition insulin itself, the release of which is affected by these adipokines, has
autocrine effects on the β-cell. Signalling pathways which are negatively or positively affected by adipokines include one
of the main pathways activated in insulin signalling the PI3K pathway as well as pathways such as MAPK/ERK1/2 and AMPK. AC,
Adenylyl cyclase; AdipoR, Adiponectin receptor; Akt/PKB, Protein Kinase B; AMPK, AMP-activated protein kinase; ApelinR, Apelin
receptor (APJ receptor); DPP-IV, Dipeptidyl peptidase IV; ERK, Extracellular signal-regulated kinases; GLP1, Glucagon-like
peptide 1; GLP1-R, GLP1 receptor; InsR, Insulin Receptor; JAK/STAT, Janus Kinase/ Signal Transducer and Activator of Transcription;
KATP, ATP-sensitive potassium channel/sulphonylurea receptor; LepR, Leptin receptor; MAPK, Mitogen-activated protein kinases
(eg ERK, JNK, p38); NFκB, nuclear factor kappa B; NMN, nicotinamide mononucleotide; PDE-3B, phosphodiesterase-3B; PDX-1, Pancreatic
and duodenal homeobox 1; PI3K, phosphatidyl inositol 3 kinase; PKA, protein kinase A (cAMP-dependent protein kinase; PTEN,
Phosphatase and tensin homolog; TNFR-1, TNFα-receptor 1